London medical technology business grows US footprint with new acquisition

Medical technology business Smith+Nephew has announced that it has acquired American company Tusker Medical for an undisclosed amount.

Tusker, which is based in California, is the developer of the Tula System, an in-office solution for tympanostomy tubes.

The Tula System is designed to reduce the amount of tympanostomy tube placement surgeries performed on children each year - a figure which currently stands at 700,000.

Brad Cannon, president of sports medicine and ear, nose and throat (ENT) at Smith+Nephew, said: “The Tula System is a truly innovative option for physicians treating incredibly common ear conditions.

“It is a game-changer when treating children, removing the risk and stress of general anaesthesia for patients and caregivers.

“Tula is a highly complementary addition to our ENT portfolio, and we are excited to significantly improve the treatment options for surgeons and patients with the launch of this technology.”

Amir Abolfathi, president and CEO of Tusker, said: “I am immensely proud of the paediatric-focused technology that we have developed.

“Smith+Nephew is well-placed to accelerate and broaden the launch of Tula and we look forward to working together to improve the quality of life of the millions of children who suffer from ear infections every year.”

The company plans to launch the Tula System commercially in the US in the first quarter of 2020.